Dr. Jincheng Xiao 肖金成
Chief Physician, Associate Professor
Department of Minimally Invasive Intervention, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional therapy for liver, lung, and gastric cancers. Specializes in ablation treatments for tumors in the liver, lungs, bones, and soft tissues, as well as puncture drainage and management of malignant lumen stenosis.
Dr. Xiao holds a Master of Medicine from Zhengzhou University (2007) and graduated from Xinxiang Medical University (1996). As Chief Physician and Associate Professor, Dr. Xiao focuses on minimally invasive tumor therapy, including ablation and interventional procedures. Dr. Xiao has published over 30 articles and received two scientific achievement awards.
Professional roles
- Vice Chair, Lung Cancer Professional Committee, National Tumor Minimally Invasive Therapy Innovation Industry Alliance, Ministry of Science and Technology
- Standing Committee Member, Lung Cancer Minimally Invasive Comprehensive Treatment Branch, Tumor Minimally Invasive Therapy Professional Committee, China Anti-Cancer Association
- Member, Tumor Minimally Invasive Therapy Professional Committee, China Anti-Cancer Association
- Member, Thoracic Tumor Diagnosis and Treatment Expert Committee, Tumor Interventional Therapy Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Xiao Jincheng). Papers usually list the name as Jincheng Xiao or Xiao J.
Selected publications
10 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Hepatocell Carcinoma, 2025 (senior author): TACE-HAIC versus TACE as Initial Regional Therapy for Unresectable Huge Hepatocellular Carcinoma (>10 cm): A Propensity Score-Matched Study. PubMed 40980779
- Pathol Res Pract, 2023 (senior author): Circ_0001686 knockdown suppresses tumorigenesis and enhances radiosensitivity in esophagus cancer through regulating miR-876-5p/SPIN1 axis. PubMed 36459832
- Zhonghua Nei Ke Za Zhi, 2012 (senior author): [The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases]. PubMed 23327960
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion